Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2017

Open Access 01-12-2017 | Research

Health-related quality of life in children with congenital adrenal hyperplasia

Authors: Alyssa Halper, Mary C. Hooke, Maria Teresa Gonzalez-Bolanos, Nancy Vanderburg, Thang N. Tran, Jane Torkelson, Kyriakie Sarafoglou

Published in: Health and Quality of Life Outcomes | Issue 1/2017

Login to get access

Abstract

Background

Children with congenital adrenal hyperplasia (CAH) require life-long glucocorticoid replacement and have daily intermittent hyper/hypocortisolemia and hyperandrogenemia. Health-related quality of life (HRQL) is important for understanding the impact the disease and therapy have on physical, mental, emotional, and social functioning. Little is known about HRQL in CAH. We compared HRQL in children with CAH to healthy norms and examined how these scores related to physiologic variables.

Methods

A cross-sectional study examined 45 patients (mean age 8.2(4.5) years). Thirty-two self-reported their quality of life (QoL) on the PedsQL™ Generic Core Scale and PedsQL™ Fatigue Scale, and 44 parents completed a parent report. Bone age Z-scores were calculated from the most recent bone age.

Results

Children with CAH did not report lower QoL than healthy norms. However, their parents reported lower overall QoL and fatigue scores than parents of healthy norms. Children with CAH rated sleep poorer than their parents. QoL scores did not differ by sex or CAH subtype and were not associated with total daily hydrocortisone dose. Bone age Z-scores were negatively associated with child-reported emotional health and cognitive fatigue.

Conclusions

Parents of children with CAH reported a negative impact of disease on their children’s QoL, but their children did not. The negative associations between bone age Z-scores and emotional health and cognitive fatigue suggest an impact from chronic hypocortisolemia and hyperandrogenemia.
Literature
1.
go back to reference Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:4133–60.CrossRefPubMedPubMedCentral Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:4133–60.CrossRefPubMedPubMedCentral
2.
go back to reference Sarafoglou K, Zimmerman CL, Gonzalez-Bolanos MT, Willis BA, Brundage R. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia. J Investig Med. 2015;63:35–41.CrossRefPubMed Sarafoglou K, Zimmerman CL, Gonzalez-Bolanos MT, Willis BA, Brundage R. Interrelationships among cortisol, 17-hydroxyprogesterone, and androstenendione exposures in the management of children with congenital adrenal hyperplasia. J Investig Med. 2015;63:35–41.CrossRefPubMed
3.
go back to reference Gilban DL, Alves Junior PA, Beserra IC. Health related quality of life of children and adolescents with congenital adrenal hyperplasia in Brazil. Health Qual Life Outcomes. 2014;12:107.CrossRefPubMedPubMedCentral Gilban DL, Alves Junior PA, Beserra IC. Health related quality of life of children and adolescents with congenital adrenal hyperplasia in Brazil. Health Qual Life Outcomes. 2014;12:107.CrossRefPubMedPubMedCentral
4.
go back to reference Yau M, Vogiatzi M, Lewkowitz-Shpuntoff A, Nimkarn S, Lin-Su K. Health-Related Quality of Life in Children with Congenital Adrenal Hyperplasia. Horm Res Paediatr. 2015;84:165–71.CrossRefPubMed Yau M, Vogiatzi M, Lewkowitz-Shpuntoff A, Nimkarn S, Lin-Su K. Health-Related Quality of Life in Children with Congenital Adrenal Hyperplasia. Horm Res Paediatr. 2015;84:165–71.CrossRefPubMed
5.
go back to reference Varni JW, Burwinkle TM, Seid M. The PedsQL as a pediatric patient-reported outcome: reliability and validity of the PedsQL Measurement Model in 25,000 children. Expert Rev Pharmacoecon Outcomes Res. 2005;5:705–19.CrossRefPubMed Varni JW, Burwinkle TM, Seid M. The PedsQL as a pediatric patient-reported outcome: reliability and validity of the PedsQL Measurement Model in 25,000 children. Expert Rev Pharmacoecon Outcomes Res. 2005;5:705–19.CrossRefPubMed
6.
go back to reference Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3:329–41.CrossRefPubMed Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3:329–41.CrossRefPubMed
7.
go back to reference Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer. 2002;94:2090–106.CrossRefPubMed Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer. 2002;94:2090–106.CrossRefPubMed
8.
go back to reference Varni JW, Limbers CA, Bryant WP, Wilson DP. Assessment of fatigue in pediatric patients with short stature utilizing the PedsQL™ multidimensional fatigue scale. Chil Health Care. 2012;41:162–81.CrossRef Varni JW, Limbers CA, Bryant WP, Wilson DP. Assessment of fatigue in pediatric patients with short stature utilizing the PedsQL™ multidimensional fatigue scale. Chil Health Care. 2012;41:162–81.CrossRef
9.
go back to reference Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800–12.CrossRefPubMed Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care. 2001;39:800–12.CrossRefPubMed
10.
go back to reference Kwon JH, Lee HA, Kim YJ, Lee H, Park EA, Cho SJ, Gwak HS, Ha E, Park H, Kim HS. Effects of Adrenal Androgen Levels on Bone Age Advancement in Prepubertal Children: Using the Ewha Birth and Growth Cohort Study. J Korean Med Sci. 2017;32:968–73.CrossRefPubMedPubMedCentral Kwon JH, Lee HA, Kim YJ, Lee H, Park EA, Cho SJ, Gwak HS, Ha E, Park H, Kim HS. Effects of Adrenal Androgen Levels on Bone Age Advancement in Prepubertal Children: Using the Ewha Birth and Growth Cohort Study. J Korean Med Sci. 2017;32:968–73.CrossRefPubMedPubMedCentral
12.
go back to reference Ingerski LM, Modi AC, Hood KK, Pai AL, Zeller M, Piazza-Waggoner C, Driscoll KA, Rothenberg ME, Franciosi J, Hommel KA. Health-related quality of life across pediatric chronic conditions. J Pediatr. 2010;156:639–44.CrossRefPubMedPubMedCentral Ingerski LM, Modi AC, Hood KK, Pai AL, Zeller M, Piazza-Waggoner C, Driscoll KA, Rothenberg ME, Franciosi J, Hommel KA. Health-related quality of life across pediatric chronic conditions. J Pediatr. 2010;156:639–44.CrossRefPubMedPubMedCentral
13.
go back to reference Cantrell MA, Kelly MM. Health-related quality of life for chronically ill children. MCN Am J Matern Child Nurs. 2015;40:24–31.CrossRefPubMed Cantrell MA, Kelly MM. Health-related quality of life for chronically ill children. MCN Am J Matern Child Nurs. 2015;40:24–31.CrossRefPubMed
14.
go back to reference Han TS, Krone N, Willis DS, Conway GS, Hahner S, Rees DA, Stimson RH, Walker BR, Arlt W, Ross RJ. United Kingdom Congenital adrenal Hyperplasia Adult Study E: Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE). Eur J Endocrinol. 2013;168:887–93.CrossRefPubMedPubMedCentral Han TS, Krone N, Willis DS, Conway GS, Hahner S, Rees DA, Stimson RH, Walker BR, Arlt W, Ross RJ. United Kingdom Congenital adrenal Hyperplasia Adult Study E: Quality of life in adults with congenital adrenal hyperplasia relates to glucocorticoid treatment, adiposity and insulin resistance: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE). Eur J Endocrinol. 2013;168:887–93.CrossRefPubMedPubMedCentral
15.
go back to reference Nella AA, Mallappa A, Perritt AF, Gounden V, Kumar P, Sinaii N, Daley LA, Ling A, Liu CY, Soldin SJ, Merke DP. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2016;101:4690–8.CrossRefPubMed Nella AA, Mallappa A, Perritt AF, Gounden V, Kumar P, Sinaii N, Daley LA, Ling A, Liu CY, Soldin SJ, Merke DP. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab. 2016;101:4690–8.CrossRefPubMed
16.
go back to reference Johannsson G, Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engstrom BE, Olsson T, Ragnarsson O, Ryberg M, et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab. 2012;97:473–81.CrossRefPubMed Johannsson G, Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engstrom BE, Olsson T, Ragnarsson O, Ryberg M, et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab. 2012;97:473–81.CrossRefPubMed
17.
go back to reference Reisch N, Hahner S, Bleicken B, Flade L, Pedrosa Gil F, Loeffler M, Ventz M, Hinz A, Beuschlein F, Allolio B, et al. Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency. Clin Endocrinol. 2011;74:166–73.CrossRef Reisch N, Hahner S, Bleicken B, Flade L, Pedrosa Gil F, Loeffler M, Ventz M, Hinz A, Beuschlein F, Allolio B, et al. Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency. Clin Endocrinol. 2011;74:166–73.CrossRef
18.
go back to reference Tanaka T, Tai S, Morisaki Y, Tachibana K, Kambayashi Y, Chihara K, Seino Y, Fujieda K. Evaluation of Quality of Life in Children with GH Deficiency and Idiopathic Short Stature Using the Child Behavior Checklist. Clin Pediatr Endocrinol. 2009;18:15–22.CrossRefPubMedPubMedCentral Tanaka T, Tai S, Morisaki Y, Tachibana K, Kambayashi Y, Chihara K, Seino Y, Fujieda K. Evaluation of Quality of Life in Children with GH Deficiency and Idiopathic Short Stature Using the Child Behavior Checklist. Clin Pediatr Endocrinol. 2009;18:15–22.CrossRefPubMedPubMedCentral
19.
go back to reference Forss M, Batcheller G, Skrtic S, Johannsson G. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey. BMC Endocr Disord. 2012;12:8.CrossRefPubMedPubMedCentral Forss M, Batcheller G, Skrtic S, Johannsson G. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey. BMC Endocr Disord. 2012;12:8.CrossRefPubMedPubMedCentral
20.
go back to reference Peters CJ, Hill N, Dattani MT, Charmandari E, Matthews DR, Hindmarsh PC. Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy. Clin Endocrinol. 2013;78:347–51.CrossRef Peters CJ, Hill N, Dattani MT, Charmandari E, Matthews DR, Hindmarsh PC. Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy. Clin Endocrinol. 2013;78:347–51.CrossRef
21.
go back to reference Raikkonen K, Matthews KA, Pesonen AK, Pyhala R, Paavonen EJ, Feldt K, Jones A, Phillips DI, Seckl JR, Heinonen K, et al. Poor sleep and altered hypothalamic-pituitary-adrenocortical and sympatho-adrenal-medullary system activity in children. J Clin Endocrinol Metab. 2010;95:2254–61.CrossRefPubMed Raikkonen K, Matthews KA, Pesonen AK, Pyhala R, Paavonen EJ, Feldt K, Jones A, Phillips DI, Seckl JR, Heinonen K, et al. Poor sleep and altered hypothalamic-pituitary-adrenocortical and sympatho-adrenal-medullary system activity in children. J Clin Endocrinol Metab. 2010;95:2254–61.CrossRefPubMed
22.
go back to reference Kumari M, Badrick E, Ferrie J, Perski A, Marmot M, Chandola T. Self-reported sleep duration and sleep disturbance are independently associated with cortisol secretion in the Whitehall II study. J Clin Endocrinol Metab. 2009;94:4801–9.CrossRefPubMedPubMedCentral Kumari M, Badrick E, Ferrie J, Perski A, Marmot M, Chandola T. Self-reported sleep duration and sleep disturbance are independently associated with cortisol secretion in the Whitehall II study. J Clin Endocrinol Metab. 2009;94:4801–9.CrossRefPubMedPubMedCentral
23.
go back to reference Sanches SA, Wiegers TA, Otten BJ. Claahsen-van der Grinten HL: Physical, social and societal functioning of children with congenital adrenal hyperplasia (CAH) and their parents, in a Dutch population. Int J Pediatr Endocrinol. 2012;2012:2.CrossRefPubMedPubMedCentral Sanches SA, Wiegers TA, Otten BJ. Claahsen-van der Grinten HL: Physical, social and societal functioning of children with congenital adrenal hyperplasia (CAH) and their parents, in a Dutch population. Int J Pediatr Endocrinol. 2012;2012:2.CrossRefPubMedPubMedCentral
Metadata
Title
Health-related quality of life in children with congenital adrenal hyperplasia
Authors
Alyssa Halper
Mary C. Hooke
Maria Teresa Gonzalez-Bolanos
Nancy Vanderburg
Thang N. Tran
Jane Torkelson
Kyriakie Sarafoglou
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2017
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-017-0769-7

Other articles of this Issue 1/2017

Health and Quality of Life Outcomes 1/2017 Go to the issue